FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311018708> ?p ?o ?g. }

• W4311018708 abstract "Severe alcohol-associated hepatitis (SAH) patients with infections have a high short-term mortality rate. Gut microbiota dysbiosis plays an important role in the pathogenesis of SAH. Preliminary studies have demonstrated long-term benefits with healthy donor fecal microbiota transplantation (FMT). Data on FMT compared with pentoxifylline for SAH and relevant gut microbial changes are lacking in literature.From January 2019 to February 2021, retrospective analysis of a single hospital's records revealed 47 SAH patients undergoing FMT (100 mL/day via nasoduodenal tube for 7 days) and 25 matched patients receiving pentoxifylline (400 mg/8 h for 28 days). The primary end point was a 6-month survival rate. Secondary end points included incidence of ascites, hepatic encephalopathy, infections, acute kidney injury, and gut microbiota changes between post-therapy groups. Biomarker discovery and network analysis were also performed to identify significant taxa of gut microbiota in post-treatment groups in retrospectively stored stool samples.All were males. The 6-month survival rate was higher in the patients undergoing FMT than in patients receiving pentoxifylline (83.0% vs 56.0%, P = 0.012). At the end of 6-month follow-up, the incidences of clinically significant ascites (56.0% vs 25.5%, P = 0.011), hepatic encephalopathy (40.0% vs 10.6%, P = 0.003), and critical infections (52.0% vs 14.9%, P < 0.001) in patients administered pentoxifylline were significantly higher than those in patients treated with FMT. At 3 months, biomarker analysis revealed a significant abundance of Bifidobacterium and Eggerthella in the FMT group and the pentoxifylline group, respectively. At 6 months, Bifidobacterium in the FMT group and pathogenic Aerococcaceae in the pentoxifylline group were notable. Network analysis showed beneficial taxa (Bifidobacterium) as a central influencer in those undergoing FMT at 6 months.Healthy donor FMT improved survival rate and reduced liver-related complications compared with pentoxifylline. These clinical benefits were associated with favorable modulation of intestinal bacterial communities. Difficult-to-treat SAH patients may be safely bridged to transplantation using FMT. Controlled trials evaluating long-term outcomes are an unmet need." @default.
• W4311018708 created "2022-12-22" @default.
• W4311018708 creator A5042024003 @default.
• W4311018708 creator A5051836172 @default.
• W4311018708 creator A5052891945 @default.
• W4311018708 creator A5059083539 @default.
• W4311018708 creator A5063915211 @default.
• W4311018708 creator A5081251473 @default.
• W4311018708 creator A5081384196 @default.
• W4311018708 date "2022-01-01" @default.
• W4311018708 modified "2023-10-16" @default.
• W4311018708 title "Clinical outcomes and gut microbiota analysis of severe alcohol-associated hepatitis patients undergoing healthy donor fecal transplant or pentoxifylline therapy: single-center experience from Kerala" @default.
• W4311018708 cites W1980058685 @default.
• W4311018708 cites W1985808363 @default.
• W4311018708 cites W1997287683 @default.
• W4311018708 cites W2034801500 @default.
• W4311018708 cites W2038579078 @default.
• W4311018708 cites W2039440843 @default.
• W4311018708 cites W2046180836 @default.
• W4311018708 cites W2068825157 @default.
• W4311018708 cites W2083457154 @default.
• W4311018708 cites W2089033840 @default.
• W4311018708 cites W2096566958 @default.
• W4311018708 cites W2163154504 @default.
• W4311018708 cites W2259551399 @default.
• W4311018708 cites W2283572643 @default.
• W4311018708 cites W2328023807 @default.
• W4311018708 cites W2426632426 @default.
• W4311018708 cites W2518877078 @default.
• W4311018708 cites W2547429997 @default.
• W4311018708 cites W2549253162 @default.
• W4311018708 cites W2623146054 @default.
• W4311018708 cites W2690365708 @default.
• W4311018708 cites W2801976704 @default.
• W4311018708 cites W2809675996 @default.
• W4311018708 cites W2900560698 @default.
• W4311018708 cites W2955671776 @default.
• W4311018708 cites W2994923251 @default.
• W4311018708 cites W3035015153 @default.
• W4311018708 cites W3093405588 @default.
• W4311018708 cites W4206220825 @default.
• W4311018708 cites W4210605822 @default.
• W4311018708 cites W4225574647 @default.
• W4311018708 doi "https://doi.org/10.1093/gastro/goac074" @default.
• W4311018708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36479155" @default.
• W4311018708 hasPublicationYear "2022" @default.
• W4311018708 type Work @default.
• W4311018708 citedByCount "3" @default.
• W4311018708 countsByYear W43110187082023 @default.
• W4311018708 crossrefType "journal-article" @default.
• W4311018708 hasAuthorship W4311018708A5042024003 @default.
• W4311018708 hasAuthorship W4311018708A5051836172 @default.
• W4311018708 hasAuthorship W4311018708A5052891945 @default.
• W4311018708 hasAuthorship W4311018708A5059083539 @default.
• W4311018708 hasAuthorship W4311018708A5063915211 @default.
• W4311018708 hasAuthorship W4311018708A5081251473 @default.
• W4311018708 hasAuthorship W4311018708A5081384196 @default.
• W4311018708 hasBestOaLocation W43110187082 @default.
• W4311018708 hasConcept C126322002 @default.
• W4311018708 hasConcept C203014093 @default.
• W4311018708 hasConcept C2777165150 @default.
• W4311018708 hasConcept C2777214474 @default.
• W4311018708 hasConcept C2777364826 @default.
• W4311018708 hasConcept C2780325230 @default.
• W4311018708 hasConcept C2780404050 @default.
• W4311018708 hasConcept C2780496750 @default.
• W4311018708 hasConcept C2911091166 @default.
• W4311018708 hasConcept C539455810 @default.
• W4311018708 hasConcept C71924100 @default.
• W4311018708 hasConcept C90924648 @default.
• W4311018708 hasConceptScore W4311018708C126322002 @default.
• W4311018708 hasConceptScore W4311018708C203014093 @default.
• W4311018708 hasConceptScore W4311018708C2777165150 @default.
• W4311018708 hasConceptScore W4311018708C2777214474 @default.
• W4311018708 hasConceptScore W4311018708C2777364826 @default.
• W4311018708 hasConceptScore W4311018708C2780325230 @default.
• W4311018708 hasConceptScore W4311018708C2780404050 @default.
• W4311018708 hasConceptScore W4311018708C2780496750 @default.
• W4311018708 hasConceptScore W4311018708C2911091166 @default.
• W4311018708 hasConceptScore W4311018708C539455810 @default.
• W4311018708 hasConceptScore W4311018708C71924100 @default.
• W4311018708 hasConceptScore W4311018708C90924648 @default.
• W4311018708 hasLocation W43110187081 @default.
• W4311018708 hasLocation W43110187082 @default.
• W4311018708 hasLocation W43110187083 @default.
• W4311018708 hasOpenAccess W4311018708 @default.
• W4311018708 hasPrimaryLocation W43110187081 @default.
• W4311018708 hasRelatedWork W156267672 @default.
• W4311018708 hasRelatedWork W2006729455 @default.
• W4311018708 hasRelatedWork W2370889574 @default.
• W4311018708 hasRelatedWork W2379893296 @default.
• W4311018708 hasRelatedWork W2469844583 @default.
• W4311018708 hasRelatedWork W2737137833 @default.
• W4311018708 hasRelatedWork W2957174061 @default.
• W4311018708 hasRelatedWork W3000311560 @default.
• W4311018708 hasRelatedWork W3042288232 @default.
• W4311018708 hasRelatedWork W2922528030 @default.
• W4311018708 hasVolume "10" @default.
• W4311018708 isParatext "false" @default.
• W4311018708 isRetracted "false" @default.

• next